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A fatal case of anthrax occurred in an injecting drug 
user in Germany, in December 2009. A potential link 
to similar cases in Scotland in the same time period is 
currently under investigation.
The Robert Koch Institute, in collaboration with the 
Friedrich Loeffler Institute in Jena, the Federal Research 
Institute for Animal Health, and the respective local 
and regional health authorities in the Aachen district, 
North-Rhine-Westphalia, Germany, are currently inves-
tigating a fatal case of anthrax in a 42 year-old male 
injecting drug user.
The individual was hospitalised on 6 December 2009, 
complaining of a swelling of his leg following drug 
injection into the popliteal fossa – reportedly attempt-
ing to inject into a vein. He probably injected heroin, 
however, details are unknown. Following treatment 
with meropenem and surgical debridement of a subse-
quent necrotising fasciitis, the patient died with mul-
tiorgan failure on 13 December 2009. Anthrax had not 
been suspected clinically. 
Spore-forming bacteria from a wound swab specimen 
were identified, and on 18 December, the diagnosis of 
anthrax was confirmed by PCR. The last case of human 
anthrax in Germany had been reported in 1994, at that 
time affecting a 66 year-old man [1].
At this point in time, it is not clear whether there is a 
link between this case and the anthrax outbreak among 
injecting drug users in Scotland. As far as we know, the 
deceased had no travel history to Scotland. However, 
it can be assumed that other drug users in the same 
area in Germany, or perhaps elsewhere in the country, 
have been exposed. In case the hypothesis of a poten-
tial link to the Scottish cases proves true, it might well 
be that also other countries have been supplied with 
contaminated injectable drugs. 
We launched an epidemiological investigation and 
exchanged information with the colleagues in the 
United Kingdom and, in particular, Scotland to coordi-
nate the approach.
So far, the following measures have been taken:  
•	We	 have	 distributed	 information	 to	 public	 health 
colleagues, medical care facilities and low-threshold 
facilities in Germany to raise awareness of the event. 
•	We	 are	 collecting	 information	 on	 the	 case	 and	 his	
contacts, and on the substances consumed. 
•	We	attempt	further	case	finding.	
•	We	 aim	 at	 a	microbiological	 comparison	 of	 isolates	
to establish a potential epidemiological link with the 
Scottish cases. 
The success of the epidemiological investigation will 
rely on public health authorities’ efforts, alertness 
amongst clinicians and medical microbiologists, but 
also on the degree to which drug users themselves can 
be reached. Therefore, it is of utmost importance to uti-
lise existing communication channels to inform those 
who might be at risk.
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